Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non–Muscle-Invasive Bladder Cancer
- DOI
- 10.1200/po-26-00676
- Published
- 2026-11
- Container
- JCO Precision Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/po-26-00676,
title = {Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non–Muscle-Invasive Bladder Cancer},
author = {Shiwang Huang and Zihan Xue and Ning Kang and Boyue Ma and Kaipeng Jia and Yuda Lin and Peng Li and Chong Shen and Bin Fu and Hailong Hu and Yunkai Qie},
year = {2026},
journal = {JCO Precision Oncology},
doi = {10.1200/po-26-00676},
url = {https://doi.org/10.1200/po-26-00676}
}RIS
TY - JOUR TI - Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non–Muscle-Invasive Bladder Cancer AU - Shiwang Huang AU - Zihan Xue AU - Ning Kang AU - Boyue Ma AU - Kaipeng Jia AU - Yuda Lin AU - Peng Li AU - Chong Shen AU - Bin Fu AU - Hailong Hu AU - Yunkai Qie PY - 2026 JO - JCO Precision Oncology DO - 10.1200/po-26-00676 UR - https://doi.org/10.1200/po-26-00676 ER -
APA
Huang, S., Xue, Z., Kang, N., Ma, B., Jia, K., Lin, Y., Li, P., Shen, C., Fu, B., Hu, H., & Qie, Y. (2026). Postresection Urinary Tumor DNA Refines Residual Disease Assessment and Recurrence Risk Stratification in Non–Muscle-Invasive Bladder Cancer. JCO Precision Oncology. https://doi.org/10.1200/po-26-00676
Source records
- crossref · retrieved 2026-11-06T04:59:23.943Z